3 chapters across the catalog
Pfizer released preliminary lab data suggesting a third dose of its vaccine boosts immunity against the Delta and Beta variants. NPR's coverage of the announcement was criticized for acting as "stenography" for Pfizer's investor calls rather than providing critical journalism. Pfizer CEO Albert Bourla projected the need for annual boosters while reporting $8 billion in second-quarter vaccine revenue.
Joe Biden Pandemic Comments and Pfizer Revenue Projections
President Joe Biden made contradictory statements regarding the status of the pandemic during a recent town hall. Financial analysts noted that Pfizer expects to deliver four billion vaccine doses next year, potentially generating massive revenue through "value-add" products like combined COVID-19 and flu shots. This strategy mirrors historical patterns seen during the swine flu outbreak, where multiple vaccines were bundled for commercial efficiency.
Pfizer Revenue Projections, Joe Biden Vaccines.gov Gaffe
Pfizer is projected to earn $26 billion in 2021 from COVID-19 vaccines after a $4 billion first quarter. President Joe Biden is criticized for a verbal gaffe where he directed citizens to "vaccines dot gum" instead of vaccines.gov. The hosts argue that mainstream media has shifted from medical reporting to pure pharmaceutical marketing.
